• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Contract Manufacturing: Trials & Tribulations of Today’s Supply Chains

    Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality

    Nutrition and Flavor: Formulating for Modern Product Preferences

    What Do Consumers Know About the Gut Microbiome?

    How Will the European Green Deal Impact Dietary Supplements?
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market

    Tazo Transitions to Regenerative Organic Agriculture

    Protein Ingredient Formulated for Chronic Kidney Disease Patients

    IADSA Calls for Addressing Discrepancies in Vitamin C Recommendations

    Caffeine-Free Energy Supplement Linked to Alertness, Fatigue Benefits
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market

    Tazo Transitions to Regenerative Organic Agriculture

    Protein Ingredient Formulated for Chronic Kidney Disease Patients

    IADSA Calls for Addressing Discrepancies in Vitamin C Recommendations

    Caffeine-Free Energy Supplement Linked to Alertness, Fatigue Benefits
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market

    Tazo Transitions to Regenerative Organic Agriculture

    Protein Ingredient Formulated for Chronic Kidney Disease Patients

    IADSA Calls for Addressing Discrepancies in Vitamin C Recommendations

    Caffeine-Free Energy Supplement Linked to Alertness, Fatigue Benefits
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Caffeine-Free Energy Supplement Linked to Alertness, Fatigue Benefits

    Monk Fruit Sweetener May Have Prebiotic Activity, Study Finds

    People with Low-Fiber Diets Benefit the Most from Fiber Supplements, Study Finds

    Gut Microbiome May Be Part of Link Between Red Meat and Heart Disease Risk

    Nutritional Growth Solutions’ Healthy Heights Enters South Korea Market
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    ESHA Research

    Bioenergy Life Science, Inc. (BLS)

    Gencor

    Aiya America, Inc. (Aiya Matcha)

    Ecuadorian Rainforest
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    ESHA Research

    Bioenergy Life Science, Inc. (BLS)

    Gencor

    Aiya America, Inc. (Aiya Matcha)

    Ecuadorian Rainforest
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    ODSP Director Cara Welch Discusses Agency Priorities

    Facility inspections, NDIs, enforcement, and education are all top-of-mind.

    ODSP Director Cara Welch Discusses Agency Priorities
    Related CONTENT
    • Food Processing for Health and Wellness
    • Formulating for Nutrient Bioavailability
    • Packaged Facts: Plant-Forward Dieting On the Rise
    • JAMA: FDA Warning Letters Fail to Result In Removal of Illegal Supplement Ingredients
    • NJ Labs Warns Industry of FDA Warning Letters on Water Testing
    Mike Montemarano, Associate Editor 07.05.22
    Cara Welch, director of FDA’s Office of Dietary Supplement Programs (ODSP), discussed the agency’s legislative priorities during the American Conference Institute (ACI) and Council for Responsible Nutrition (CRN) Legal, Regulatory, and Compliance Forum on Dietary Supplements held in New York in June.
     
    First off, the agency is discussing a number of options to increase its inspectional capacity, Welch said. According to the National Institutes of Health, at the time the Dietary Supplement Health and Education Act was signed into law in 1994, an estimated 600 U.S. dietary supplement manufacturers marketed about 4,000 products.
     
    With an increase to between 50,000 and 80,000 products on the market today, “I think we can all admit that the dietary supplements marketplace has changed since 1994,” Welch said. “Supply chains have globalized, and the internet was introduced as a retail and marketing channel. Products are precisely designed to include specific formulations and mixtures of ingredients, some of which are designer ingredients or highly concentrated and purified constituents.”
     
    Rethinking Inspections
    In the three years prior to the COVID-19 pandemic, FDA conducted about 500-600 facility inspections each year, comprising approximately 5% of all domestic facilities registered with the agency. Since the onset of the pandemic, facility inspections numbered in the mid to high 200s.
     
    “We don’t have a good picture of the compliance status of the industry. There are limitations to how many inspections we can do,” Welch said. “As we move back to typical inspection approaches, we’re looking not just at the ones we need to do now, but an entire backlog of the in-person inspections we missed. Our current perspective is that we need to bring a new sense of urgency to the discussion and I think we’re headed in the right direction.”
     
    Welch said that remote regulatory assessments (RRAs), a program which began during the pandemic, will likely continue in some form based on the success seen when the option was introduced during the pandemic. This voluntary assessment by FDA, which is done outside of formal or official inspections, allows manufacturing firms to have FDA representative evaluate their cGMP (current Good Manufacturing Practices) documentation informally.
     
    “While it doesn’t officially count as a remote inspection, it allows us to keep our fingers on the pulse of manufacturing conditions,” Welch said. “We’re still not getting the kind of number of participants that we want, but it could provide a pretty good picture of a facility’s compliance.”
     
    While Welch said the FDA isn’t quite ready to implement anything of the sort, the agency hasn’t ruled out the idea of outsourcing domestic inspections to third-party certifiers, similar to how foreign facilities are able to be tested under the Food Safety Modernization Act (FSMA).
     
    “ODSP plays a role in policy and regulation, but inspections are handled by the Office of Regulatory Affairs. ORA has a really important part to play in these discussions, and we need to know what their goals are in depth,” Welch said, such as the number of inspections it plans to conduct, what these inspections should prioritize, and if there are similar programs that FDA can model.
     
    New Dietary Ingredients
    This May, FDA issued draft guidance on enforcement discretion it plans to give firms that have introduced new dietary ingredients to the marketplace without the proper New Dietary Ingredient Notification (NDIN). The comment period for this draft guidance ends on July 19.
     
    Since the introduction of DSHEA, FDA has received over 1,200 notifications, Welch said, though the agency estimates there are 4,600 products on the market that warranted notifications. The proposed amnesty period, if finalized, would offer ingredient manufacturers the chance to avoid the penalties that come with this failure to notify.
     
    “When this guidance is finalized, firms will have 180 days to submit an NDIN that already should’ve been submitted, and retribution will not happen. We want data, primarily safety information, in order to help substantiate how safe the current marketplace is. The goal here is to increase the amount of information we have,” Welch said. “We hope that the pool of firms not willing to comply with NDI regulations will be much smaller, and this will help us identify those firms who are simply choosing not to be in compliance so that we could take action. I’m really hopeful that we get the buy-in from firms to submit these NDINs.”
     
    Welch stressed her hope that companies will not neglect to submit late NDINs based on unanswered questions about what amnesty entails, and that finalizing certain portions of the 102-page guidance in order to expedite it is the agency’s preference.
     
    The success rate for all NDINs over the past 27 years, in terms of those which receive acknowledgements from the FDA with no objections, sits at 30%; 36% of NDINs resulted in the FDA finding certain inadequacies following a review; 19% of NDINs submitted to the agency contained incomplete information. Lastly, 15% of NDINs were for products that were not legal dietary ingredients.
     
    Amid these 1,200 notifications, various issues tracking the success rate of re-submitted products exist, such as when an ingredient or a firm changes its name, and little data on the success rate of meeting with FDA to discuss an ingredient pre-NDIN exists, though that would likely be a promising figure, Welch said.
     
    “I’m really encouraged by an increase, year over year, in the proportion of NDINs which receive good acknowledgement letters,” Welch said. “Notifications coming in have been better than before at giving us a really good picture of the ingredient at hand. Our staff has also put in a lot of effort into helping firms get a good letter. They work and meet with the notifiers, and might go back to a firm with questions that we think could be answered in order to substantiate an ingredient’s safety.”
     
    Further, the agency is less concerned about confusion as to whether an ingredient should have entered the marketplace via the Generally Recognized As Safe (GRAS) route, reserved for dietary ingredients already in the food supply.
     
    “The burden is on us to prove this is the case, and I think that’s an important thing to think about when it comes to the amnesty period,” Welch said. “We want to go ahead and make it easy as possible for people to participate in amnesty, and the best thing for us to do right now is shrink the pool of unknown elements.”
     
    Enforcement
    This year, the roundup of FDA’s enforcement activity within the dietary supplements market included 111 warning letters issued to firms the agency deemed to be in regulatory violation, up from 49 warning letters issued in 2020. “These warning letters serve as a notice to a firm which provides them with what we consider to be our complaint,” Welch said. “Almost all firms choose to comply, and when they don’t comply, we may progress to more serious enforcement action. Generally, we have 1-4 injunctions per year, along with one or two product seizures.”
     
    Welch said that despite FDA’s warning letter campaigns, which tend to publicly target and highlight one or more problematic ingredients that the agency considers illegal to market in dietary supplements, several ingredients continue to present issues. Specifically, she named 1,3-DMAA, which was being sold in products that were the subject of one high-profile seizure, along with products containing other ingredients such as DMHA, phenibut, and kratom.
     
    “We ask ourselves how we could get better at this and get to the point that the first time we warn about an ingredient, we are presented with information that shows us we were mistaken, or that this ingredient disappears from commerce,” Welch said. “We’ve gotten some suggestions, and these suggestions are not far from our approach.”
     
    Most notably, aside from engaging in more seizures and injunctions following warning letters, Welch said that the agency received suggestions to collaborate with retailers in order to remove illegal products from the marketplace in a more swift and widespread manner.
     
    “Sometimes a seizure or an injunction isn’t the best option, or it isn’t feasible. It takes a lot of resources between us and the Office of Regulatory Affairs, and the Department of Justice,” Welch said. “I see both educating and communicating as something I’d like to see us do more of.
     
    “Responsible retailers, when made aware of a violation,” she suggested, “will do their due diligence to not sell these products. FDA’s role here comes down to communicating a violation, and differentiating compliant products from those other products that are just profiting off of the industry’s efforts to be compliant. Retailers are a part of differentiating the compliant side of the marketplace.”
     
    Welch said that FDA’s communication should also go beyond retailers themselves.
     
    “To this end, FDA recently commissioned and released an education initiative called ‘Supplement Your Knowledge’ which contains information for consumers, educators, and healthcare professionals to broaden their understandings of dietary supplements,” Welch said.
    Related Searches
    • Quality & Safety
    • Regulations
    • Dietary Supplements
    Related Knowledge Center
    • Dietary Supplements
    • Quality & Safety
    • Regulations
    Suggested For You
    Food Processing for Health and Wellness Food Processing for Health and Wellness
    Formulating for Nutrient Bioavailability Formulating for Nutrient Bioavailability
    Packaged Facts: Plant-Forward Dieting On the Rise Packaged Facts: Plant-Forward Dieting On the Rise
    JAMA: FDA Warning Letters Fail to Result In Removal of Illegal Supplement Ingredients JAMA: FDA Warning Letters Fail to Result In Removal of Illegal Supplement Ingredients
    NJ Labs Warns Industry of FDA Warning Letters on Water Testing NJ Labs Warns Industry of FDA Warning Letters on Water Testing
    FDA Issues Final Guidance on NAC Supplements FDA Issues Final Guidance on NAC Supplements
    Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality
    FTC Official Discusses Dietary Supplement Enforcement FTC Official Discusses Dietary Supplement Enforcement
    Food Supplements Europe: Most Consumers Use Dietary Supplements Safely Food Supplements Europe: Most Consumers Use Dietary Supplements Safely
    Fi & Hi Europe Returns with Over 20,000 Global Attendees Expected Fi & Hi Europe Returns with Over 20,000 Global Attendees Expected
    United Plant Savers Launches First Film Festival United Plant Savers Launches First Film Festival
    New IADSA Chair Lauds Explorations of Supplementation in Healthcare Policy New IADSA Chair Lauds Explorations of Supplementation in Healthcare Policy
    EIRICH Machines EIRICH Machines
    CHPA Hires Two Key Personnel CHPA Hires Two Key Personnel
    FSA: Three-Quarters of U.K. Citizens Are Concerned about the Cost of Food FSA: Three-Quarters of U.K. Citizens Are Concerned about the Cost of Food

    Related Online Exclusives

    • Delivery & Dosage Technologies | Enzymes | Functional Foods & Beverages | Natural/Organic | Proteins, Peptides, Amino Acids | Research
      Food Processing for Health and Wellness

      Food Processing for Health and Wellness

      At IFT FIRST, a panel of researchers covered the benefits of upcycled materials and sustainable measures to produce health and wellness products.
      By Mike Montemarano, Associate Editor 08.09.22

    • Antioxidants | Delivery & Dosage Technologies | Fiber & Carbohydrates | Functional Foods & Beverages | Research
      Formulating for Nutrient Bioavailability

      Formulating for Nutrient Bioavailability

      At IFT FIRST, food scientists discussed innovation and insights into how we digest, absorb, and utilize nutrients.
      By Mike Montemarano, Associate Editor 08.09.22

    • Breaking News | Consumer Trends | Functional Foods & Beverages | Industry & Market News
      Packaged Facts: Plant-Forward Dieting On the Rise

      Packaged Facts: Plant-Forward Dieting On the Rise

      A new report from the market researcher breaks down the demographics and philosophies behind vegan, vegetarian, and flexitarian consumers.
      08.03.22


    • Dietary Supplements | Quality & Safety | Regulations | Testing
      JAMA: FDA Warning Letters Fail to Result In Removal of Illegal Supplement Ingredients

      JAMA: FDA Warning Letters Fail to Result In Removal of Illegal Supplement Ingredients

      According to product recall reports, just a portion of products containing illegal ingredients were recalled following the issuance of warning letters.
      By Mike Montemarano, Associate Editor 08.02.22

    • Contract Manufacturing | Industry & Market News | Quality & Safety
      NJ Labs Warns Industry of FDA Warning Letters on Water Testing

      NJ Labs Warns Industry of FDA Warning Letters on Water Testing

      Warning letters have been calling out companies that don’t validate their water systems through total organic carbon analysis.
      08.02.22

    Loading, Please Wait..
    Trending
    • First Day Life Shuts Down Children's Behavioral, Cognitive Health Claims Following Challenge
    • Study Examines Vitamin K2 Content In Cheese
    • Chenland Nutritionals Self-Affirms GRAS For Cumin UP60 Ingredient
    • Pycnogenol Evidenced To Have Skin Benefits In Dermatology Study
    Breaking News
    • ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    • Tazo Transitions to Regenerative Organic Agriculture
    • Protein Ingredient Formulated for Chronic Kidney Disease Patients
    • IADSA Calls for Addressing Discrepancies in Vitamin C Recommendations
    • Caffeine-Free Energy Supplement Linked to Alertness, Fatigue Benefits
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • A Growing Herbal Products Market Still Faces Formidable Threats, Challenges
    • Analytical Testing in Nutraceuticals: Methods and Mindsets to Uphold Quality
    • Nutrition and Flavor: Formulating for Modern Product Preferences
    • Contract Manufacturing: Trials & Tribulations of Today’s Supply Chains
    • How Will the European Green Deal Impact Dietary Supplements?
    • What Do Consumers Know About the Gut Microbiome?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Protein Ingredient Formulated for Chronic Kidney Disease Patients
    Coatings World

    Latest Breaking News From Coatings World

    USGBC Urges the House to Pass the Inflation Reduction Act
    The ChemQuest Technology Institute Enters Agreement with Universal Matter
    Sherwin-Williams’ TERRA: Embracing Community & Connection in 2023
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Seno Medical's Imagio System Wins Supplemental FDA Approval
    Brad Fluegel Joins NeuroMetrix Board of Directors
    Actuating Implant Design Prevents Scar Tissue Buildup
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Captor Therapeutics Selects CDMO for Clinical Trial Materials
    Catalent to Acquire Metrics Contract Services for $475M
    Sartorius Stedim Biotech Agrees to Acquire Albumedix
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Anomatic & Novelis Introduce Eco-Friendly Alloy
    NJPEC Announces 2022 Package of the Year Awards
    Tree Hut Introduces New Sugar Scrubs
    Happi

    Latest Breaking News From Happi

    Makeup in New York Returns to the Javits Center on Sept. 14-15
    PASS Coalition Applauds National Academy of Sciences Study on Its Support of Sunscreen as a Skin Cancer Prevention Tool
    Sally Beauty Names Winners of 2022 Cultivate Accelerator Program
    Ink World

    Latest Breaking News From Ink World

    INX to Highlight New Products at Labelexpo Americas
    Sonoco Names Aditya Gandhito Company’s First Chief Accounting Officer
    Quinacridone Pigments Market Size Projected to Reach $539 Million by 2030: Straits
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Heidelberg USA-Gallus opens new Screeny Demo Room in Pennsylvania
    Heidelberg enjoys successful start to financial year
    INX International Ink Co. brings wide product range to Labelexpo Americas
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Vapor Fresh Upgrades Plant-Based Gym Wipe Canisters
    Suominen Releases Half-Year Financial Report
    Essity Switches to Recyclable Packs for Feminine Pads
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Cortland Biomedical Adds Suite of Post-Processing Services & Technologies
    First Patient Enrolls in Sonex Health’s U.S. Clinical Study to Treat Carpal Tunnel Syndrome
    Robust Growth Forecast for Joint Reconstruction Market
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Stratasys Signs Agreement to Acquire Covestro’s Additive Manufacturing Materials Business
    The Future of Electronics RESHAPED Event Reports High Demand
    SEMI Applauds President Biden’s Signing of CHIPS and Science Act of 2022

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login